Pathophysiology of obsessive-compulsive disorder: A necessary link between phenomenology, neuropsychology, imagery and physiology

Progress in Neurobiology

Volumn 72, Issue 3, 2004, Pages 195-221

  Aouizerate, Bruno ^a,b   Guehl, Dominique ^b   Cuny, Emmanuel ^b   Rougier, Alain ^b   Bioulac, Bernard ^b   Tignol, Jean ^a   Burbaud, Pierre ^b  

^a CENTRE HOSPITALIER CHARLES PERRENS   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

ACC; BDD; body dysmorphic disorder; dizygotic twins; DLPC; dorsolateral prefrontal cortex; DZ; monozygotic twins; MZ; obsessive compulsive disorder; OCD; OFC; orbitofrontal cortex; Tourette's syndrome; TS; Y BOCS; Yale Brown Obsessive Compulsive Scale

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AMYGDALOID NUCLEUS; BASAL GANGLION; BEHAVIOR; BODY DYSMORPHIC DISORDER; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CAPSULOTOMY; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CORPUS STRIATUM; DECISION MAKING; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; EMOTIONAL STRESS; FAMILY HISTORY; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HYPOCHONDRIASIS; IMAGERY; LIMBIC SYSTEM; NERVE CELL NETWORK; NEUROIMAGING; NEUROIMMUNOLOGY; NEUROPSYCHOLOGY; NEUROSURGERY; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PHENOMENOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOTHERAPY; RATING SCALE; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; TIC;

DIAGNOSTIC IMAGING; HUMANS; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER; PYRAMIDAL TRACTS;

EID: 2342537848     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2004.02.004     Document Type: Review

References (352)

1. Adler C.M., McDonough-Ryan P., Sax K.W., Holland S.K., Arndt S., Strakowski S.M. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J. Psychiatr. Res. 34:2000;317-324
2. Akkal D., Bioulac B., Audin J., Burbaud P. Comparison of neuronal activity in the rostral supplementary and cingulate motor areas during a task with cognitive and motor demands. Eur. J. Neurosci. 15:2002;887-904
3. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375
4. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381
5. Allen A., Hollander E. Body dysmorphic disorder. Psychiatr. Clin. North Am. 23:2000;617-628
6. Alonso P., Menchon J.M., Pifarre J., Mataix-Cols D., Torres L., Salgado P., Vallejo J. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J. Clin. Psychiatry. 62:2001;535-540
7. Alptekin K., Degirmenci B., Kivircik B., Durak H., Yemez B., Derebek E., Tunca Z. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression. Psychiatry Res. 107:2001;51-56
8. Alsobrook J.P. 2nd, Zohar A.H., Leboyer M., Chabane N., Ebstein R.P., Pauls D.L. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am. J. Med. Genet. 114:2002;116-120
9. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. American Psychiatric Association, Washington, DC.
10. Andreasen N.C., Paradiso S., O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr. Bull. 24:1998;203-218
11. Antony, M.M., Downie, F., Swinson, R.P., 1998. Diagnostic issues and epidemiology in obsessive-compulsive disorder. In: Swinson, R.P., Antony, M.M., Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder. Theory, Research, and Treatment. Guilford Press, New York, pp. 3-32.
12. Aosaki T., Tsubokawa H., Ishida A., Watanabe K., Graybiel A.M., Kimura M. Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J. Neurosci. 14:1994;3969-3984
13. Aouizerate B., Pujol H., Grabot D., Faytout M., Suire K., Braud C., Auriacombe M., Martin D., Baudet J., Tignol J. Body dysmorphic disorder in a sample of cosmetic surgery applicants. Eur. Psychiatry. 18:2003;365-368
14. Apicella P. Tonically active neurons in the primate striatum and their role in the processing of information about motivationally relevant events. Eur. J. Neurosci. 16:2002;2017-2026
15. Apicella P., Ravel S., Sardo P., Legallet E. Influence of predictive information on responses of tonically active neurons in the monkey striatum. J. Neurophysiol. 80:1998;3341-3344
16. Arnold P.D., Richter M.A. Is obsessive-compulsive disorder an autoimmune disease? CMAJ. 165:2001;1353-1358
17. Azmitia, E.C., Whitaker-Azmitia, P.M., 1995. Anatomy, cell biology, and plasticity of the serotoninergic system: neuropsychopharmacological implications for the actions of psychotropic drugs. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 443-49.
18. Baer L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J. Clin. Psychiatry. 55(Suppl.):1994;18-23
19. Baker S.C., Dolan R., Frith C.D. The functional anatomy of logic: a PET study of inferential reasoning. Neuroimage. 3:1996;S218
20. Ballantine H.T. Jr., Bouckoms A.J., Thomas E.K., Giriunas I.E. Treatment of psychiatric illness by stereotactic cingulotomy. Biol. Psychiatry. 22:1987;807-819
21. Bar-Gad I., Bergman H. Stepping out of the box: information processing in the neural networks of the basal ganglia. Curr. Opin. Neurobiol. 11:2001;689-695
22. Barsky A.J. Clinical practice. The patient with hypochondriasis. N. Engl. J. Med. 345:2001;1395-1399
23. Barsky A.J., Wyshak G., Klerman G.L. Hypochondriasis. An evaluation of the DSM-III criteria in medical outpatients. Arch. Gen. Psychiatry. 43:1986;493-500
24. Barsky A.J., Wyshak G., Klerman G.L. Psychiatric comorbidity in DSM-III-R hypochondriasis. Arch. Gen. Psychiatry. 49:1992;101-108
25. Bartha R., Stein M.B., Williamson P.C., Drost D.J., Neufeld R.W., Carr T.J., Canaran G., Densmore M., Anderson G., Siddiqui A.R. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am. J. Psychiatry. 155:1998;1584-1591
26. Baxter, L.R., 1999. Functional imaging of brain systems mediating obsessive-compulsive disorder: clinical studies. In: Charney, D.S., Nestler, E.J., Bunney, B.S. (Eds.), Neurobiology of Mental Illness. Oxford University Press, New York, pp. 534-47.
27. Baxter M.G., Murray E.A. The amygdala and reward. Nat. Rev. Neurosci. 3:2002;563-573
28. Baxter L.R. Jr., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch. Gen. Psychiatry. 44:1987;211-218
29. Baxter L.R. Jr., Schwartz J.M., Mazziotta J.C., Phelps M.E., Pahl J.J., Guze B.H., Fairbanks L. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am. J. Psychiatry. 145:1988;1560-1563
30. Baxter L.R. Jr., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.K., Munford P., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch. Gen. Psychiatry. 49:1992;681-689
31. Baylis L.L., Gaffan D. Amygdalectomy and ventromedial prefrontal ablation produce similar deficits in food choice and in simple object discrimination learning for an unseen reward. Exp. Brain Res. 86:1991;617-622
32. Behar D., Rapoport J.L., Berg C.J., Denckla M.B., Mann L., Cox C., Fedio P., Zahn T., Wolfman M.G. Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. Am. J. Psychiatry. 141:1984;363-369
33. Beiser D.G., Hua S.E., Houk J.C. Network models of the basal ganglia. Curr. Opin. Neurobiol. 7:1997;185-190
34. Belger A., Puce A., Krystal J.H., Gore J.C., Goldman-Rakic P., McCarthy G. Dissociation of mnemonic and perceptual processes during spatial and nonspatial working memory using fMRI. Hum. Brain Mapp. 6:1998;14-32
35. Benazon N.R., Moore G.J., Rosenberg D.R. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J. Am. Acad. Child Adolesc. Psychiatry. 42:2003;1279-1285
36. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., Murphy D.L. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol. Psychiatry. 4:1999;463-466
37. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Arch. Gen. Psychiatry. 47:1990;840-848
38. Bergqvist P.B., Bouchard C., Blier P. Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder. Biol. Psychiatry. 45:1999;164-174
39. Bienvenu O.J., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.Y., Cullen B.A., Grados M.A., Nestadt G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol. Psychiatry. 48:2000;287-293
40. Billiet, E.A., Richter, M.A., Kennedy, J.L., 1998a. Genetics of obsessive-compulsive disorder. In: Swinson, R.P., Antony, M.M. Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder. Theory, Research, and Treatment. Guilford Press, New York, pp. 181-206.
41. Billiett E.A., Richter M.A., Sam F., Swinson R.P., Dai X.Y., King N., Badri F., Sasaki T., Buchanan J.A., Kennedy J.L. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr. Genet. 8:1998b;163-169
42. Binder D.K., Iskandar B.J. Modern neurosurgery for psychiatric disorders. Neurosurgery. 47:2000;9-21. (discussion 21-23)
43. Bingley, T., Leksell, L., Meyerson, B.A., Rylander, G., 1977. Long-term results of stereotactic anterior capsulotomy in chronic obsessive-compulsive neurosis. In: Sweet, W.H., Obrador, S., Martin-Rodriguez, J.G. (Eds.), Neurosurgical Treatment in Psychiatry, Pain and Epilepsy. University Park Press, Baltimore, pp. 287-299.
44. Boone K.B., Ananth J., Philpott L., Kaur A., Djenderedjian A. Neuropsychological deficits in OCD. Neuropsychiatry Neuropsychol. Behav. Neurol. 4:1991;110-121
45. Botvinick M., Nystrom L.E., Fissell K., Carter C.S., Cohen J.D. Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature. 402:1999;179-181
46. Brawman-Mintzer O., Lydiard R.B., Phillips K.A., Morton A., Czepowicz V., Emmanuel N., Villareal G., Johnson M., Ballenger J.C. Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am. J. Psychiatry. 152:1995;1665-1667
47. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., Kendrick A.D., Davis T.L., Jiang A., Cohen M.S., Stern C.E., Belliveau J.W., Baer L., O'Sullivan R.L., Savage C.R., Jenike M.A., Rosen B.R. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 53:1996;595-606
48. Bridges P.K., Goktepe E.O., Maratos J. A comparative review of patients with obsessional neurosis and with depression treated by psychosurgery. Br. J. Psychiatry. 123:1973;663-674
49. Broca P. Anatomie comparée des circonvolutions cérébrales: le grand lobe limbique et la scissure limbique dans la série des mammifères [Anatomic comparison of cerebral convolutions: the great limbic lobe and limbic sulci in a series of mammals]. Rev. Anthropol. Ser. 21:1878;384-498
50. Brody A.L., Saxena S., Schwartz J.M., Stoessel P.W., Maidment K., Phelps M.E., Baxter L.R. Jr. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res. 84:1998;1-6
51. Busatto G.F., Zamignani D.R., Buchpiguel C.A., Garrido G.E., Glabus M.F., Rocha E.T., Maia A.F., Rosario-Campos M.C., Campi Castro C., Furuie S.S., Gutierrez M.A., McGuire P.K., Miguel E.C. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 99:2000;15-27
52. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 4:2000;215-222
53. Bush G., Vogt B.A., Holmes J., Dale A.M., Greve D., Jenike M.A., Rosen B.R. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc. Natl. Acad. Sci. U.S.A. 99:2002;523-528
54. Camarena B., Rinetti G., Cruz C., Gomez A., de La Fuente J.R., Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am. J. Med. Genet. 105:2001;279-282
55. Carter, R., 1998. Mapping the Mind. The Orion Publishing Group Limited.
56. Carter C.S., Braver T.S., Barch D.M., Botvinick M.M., Noll D., Cohen J.D. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 280:1998;747-749
57. Cavallini M.C., Di Bella D., Pasquale L., Henin M., Bellodi L. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res. 77:1998;97-104
58. Charney, D.S., Bremner, J.D., 1999. The neurobiology of anxiety disorders: clinical studies. In: Charney, D.S., Nestler, E.J., Bunney, B.S. (Eds.), Neurobiology of Mental Illness. Oxford University Press, New York, pp. 494-517.
59. Crawford, J.R., Parker, D.M., McKinlay, W.W., 1992. A Handbook of Neuropsychological Assessment. Lawrence Erlbaum, Hove.
60. Christensen K.J., Kim S.W., Dysken M.W., Hoover K.M. Neuropsychological performance in obsessive-compulsive disorder. Biol. Psychiatry. 31:1992;4-18
61. Christenson G.A., Crow S.J. The characterization and treatment of trichotillomania. J. Clin. Psychiatry. 57(Suppl. 8):1996;42-47. (discussion 48-49)
62. Christenson G.A., Mackenzie T.B., Mitchell J.E. Characteristics of 60 adult chronic hair pullers. Am. J. Psychiatry. 148:1991a;365-370
63. Christenson G.A., Pyle R.L., Mitchell J.E. Estimated lifetime prevalence of trichotillomania in college students. J. Clin. Psychiatry. 52:1991b;415-417
64. Cohen L.J., Stein D.J., Simeon D., Spadaccini E., Rosen J., Aronowitz B., Hollander E. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J. Clin. Psychiatry. 56:1995;319-326
65. Cohen J.D., Perlstein W.M., Braver T.S., Nystrom L.E., Noll D.C., Jonides J., Smith E.E. Temporal dynamics of brain activation during a working memory task. Nature. 386:1997;604-608
66. Cottraux, J., Gerard, D., 1998. Neuroimaging and neuroanatomical issues in obsessive-compulsive disorder. In: Swinson, R.P., Antony, M.M., Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder: Theory, Research and Treatment. Guilford Press, New York, pp. 154-180.
67. Cruz C., Camarena B., King N., Paez F., Sidenberg D., de la Fuente J.R., Nicolini H. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci. Lett. 231:1997;1-4
68. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 50:1993;873-880
69. Davis, M., 1999. Functional neuroanatomy of anxiety and fear: a focus on the amygdala. In: Charney, D.S., Nestler, E.J., Bunney, B.S. (Eds.), Neurobiology of Mental Illness. Oxford University Press, New York, pp. 463-474.
70. Dehaene S., Posner M.I., Tucker D.M. Localization of a neural system for error detection and compensation. Psychol. Sci. 5:1994;303-305
71. Devinsky O., Morrell M.J., Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain. 118(Pt 1):1995;279-306
72. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature. 380:1996;69-72
73. Dougherty D.D., Baer L., Cosgrove G.R., Cassem E.H., Price B.H., Nierenberg A.A., Jenike M.A., Rauch S.L. Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am. J. Psychiatry. 159:2002;269-275
74. Drevets W.C. Neuroimaging studies of mood disorders. Biol. Psychiatry. 48:2000;813-829
75. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11:2001;240-249
76. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12:1992;3628-3641
77. Dubois, B., Verin, M, Teixeira-Ferreira, C., Sirigu, A., Pillon, B., 1994. How to study frontal lobe functions in humans. In: Thierry, A.-M., Glowinski, J., Goldman-Rakic, P.S., Christen, Y. (Eds.), Motor and Cognitive Functions of the Prefrontal Cortex. Springer-Verlag, Berlin, pp. 1-16.
78. Duncan J., Seitz R.J., Kolodny J., Bor D., Herzog H., Ahmed A., Newell F.N., Emslie H. A neural basis for general intelligence. Science. 289:2000;457-460
79. Du Toit P.L., van Kradenburg J., Niehaus D., Stein D.J. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr. Psychiatry. 42:2001;291-300
80. Ebert D., Speck O., Konig A., Berger M., Hennig J., Hohagen F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res. 74:1997;173-176
81. Eblen F., Graybiel A.M. Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J. Neurosci. 15:1995;5999-6013
82. Eidelberg D., Moeller J.R., Antonini A., Kazumata K., Dhawan V., Budman C., Feigin A. The metabolic anatomy of Tourette's syndrome. Neurology. 48:1997;927-934
83. El Mansari M., Bouchard C., Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology. 13:1995;117-127
84. Enoch M.A., Kaye W.H., Rotondo A., Greenberg B.D., Murphy D.L., Goldman D. 5-HT2A promoter polymorphism-1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet. 351:1998;1785-1786
85. Erzegovesi S., Cavallini M.C., Cavedini P., Diaferia G., Locatelli M., Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J. Clin. Psychopharmacol. 21:2001;488-492
86. Eslinger P.J., Grattan L.M. Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia. 31:1993;17-28
87. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann. N.Y. Acad. Sci. 877:1999;412-438
88. Fallon B.A., Javitch J.A., Hollander E., Liebowitz M.R. Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment. J. Clin. Psychiatry. 52:1991;457-460
89. Fallon B.A., Schneier F.R., Marshall R., Campeas R., Vermes D., Goetz D., Liebowitz M.R. The pharmacotherapy of hypochondriasis. Psychopharmacol. Bull. 32:1996;607-611
90. Fernandez-Cordoba E., Lopez-Ibor A.J. La monoclorimipramina en enfermos psiquiatricos resistentes a otros tratamientos. Acta Luso-Esp. Neurol. Psiquiatr. Ciene Afines. 26:1967;119-147
91. Fitzgerald K.D., Moore G.J., Paulson L.A., Stewart C.M., Rosenberg D.R. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol. Psychiatry. 47:2000;174-182
92. Flaherty A.W., Graybiel A.M. Input-output organization of the sensorimotor striatum in the squirrel monkey. J. Neurosci. 14:1994;599-610
93. Flament M.F., Bisserbe J.C. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J. Clin. Psychiatry. 58(Suppl. 12):1997;18-22
94. Flament M.F., Whitaker A., Rapoport J.L., Davies M., Berg C.Z., Kalikow K., Sceery W., Shaffer D. Obsessive compulsive disorder in adolescence: an epidemiological study. J. Am. Acad. Child Adolesc. Psychiatry. 27:1988;764-771
95. Flor-Henry P., Yeudall L.T., Koles Z.J., Howarth B.G. Neuropsychological and power spectral EEG investigations of the obsessive-compulsive syndrome. Biol. Psychiatry. 14:1979;119-130
96. Foa, E.B., Franklin, M.E., Kozac, M.J., 1998. Psychosocial treatments for obsessive-compulsive disorder. Literature review. In: Swinson, R.P., Antony, M.M., Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder. Theory, Research, and Treatment. Guilford Press, New York, pp. 258-276.
97. Foa E.B., Franklin M.E., Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol. Psychiatry. 52:2002;987-997
98. Frisch A., Michaelovsky E., Rockah R., Amir I., Hermesh H., Laor N., Fuchs C., Zohar J., Lerer B., Buniak S.F., Landa S., Poyurovsky M., Shapira B., Weizman R. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur. Neuropsychopharmacol. 10:2000;205-209
99. Fuster J.M. Unit activity in prefrontal cortex during delayed-response performance: neuronal correlates of transient memory. J. Neurophysiol. 36:1973;61-78
100. Gabriels L., Cosyns P., Nuttin B., Demeulemeester H., Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr. Scand. 107:2003;275-282
101. Gdowski M.J., Miller L.E., Parrish T., Nenonene E.K., Houk J.C. Context dependency in the globus pallidus internal segment during targeted arm movements. J. Neurophysiol. 85:2001;998-1004
102. Gehring W.J., Goss B., Coles M.G.H., Meyer D.E., Donchin E. A neural system for error detection and compensation. Psychol. Sci. 4:1993;385-390
103. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15:1992;285-320
104. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry. 157:2000;281-283
105. Gillies A., Arbuthnott G. Computational models of the basal ganglia. Mov. Disord. 15:2000;762-770
106. Goldman-Rakic P.S. Working memory and the mind. Scientific Am. 267:1992;111-117
107. Goktepe E.O., Young L.B., Bridges P.K. A further review of the results of sterotactic subcaudate tractotomy. Br. J. Psychiatry. 126:1975;270-280
108. Goodman W.K. Obsessive-compulsive disorder: diagnosis and treatment. J. Clin. Psychiatry. 60(Suppl. 18):1999;27-32
109. Goodman W.K., McDougle C.J., Price L.H. Pharmacotherapy of obsessive compulsive disorder. J. Clin. Psychiatry. 53(Suppl.):1992;29-37
110. Goodman W.K., Ward H., Kablinger A., Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J. Clin. Psychiatry. 58(Suppl. 5):1997;32-49
111. Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science. 265:1994;1826-1831
112. Greenberg, B.D., Murphy, D.L., Rasmussen, S.A., 2000. Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation. Psychiatr. Clin. North Am. 23, 671-686, xii.
113. Greenberg B.D., Price L.H., Rauch S.L., Friehs G., Noren G., Malone D., Carpenter L.L., Rezai A.R., Rasmussen S.A. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg. Clin. N. Am. 14:2003;199-212
114. Greist J.H. Behavior therapy for obsessive compulsive disorder. J. Clin. Psychiatry. 55(Suppl.):1994;60-88
115. Gross, R., Sasson, Y., Chopra, M., Zohar, J., 1998. Biological models of obsessive-compulsive disorder. The serotonin hypothesis. In: Swinson, R.P., Antony, M.M., Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder. Theory, Research, and Treatment. Guilford Press, New York, pp. 141-153.
116. Gunstad J., Phillips K.A. Axis I comorbidity in body dysmorphic disorder. Compr. Psychiatry. 44:2003;270-276
117. Han L., Nielsen D.A., Rosenthal N.E., Jefferson K., Kaye W., Murphy D., Altemus M., Humphries J., Cassano G., Rotondo A., Virkkunen M., Linnoila M., Goldman D. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism. Biol. Psychiatry. 45:1999;615-619
118. Hansen E.S., Hasselbalch S., Law I., Bolwig T.G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int. J. Neuropsychopharmacol. 5:2002;1-10
119. Hassani O.K., Cromwell H.C., Schultz W. Influence of expectation of different rewards on behavior-related neuronal activity in the striatum. J. Neurophysiol. 85:2001;2477-2489
120. Head D., Bolton D., Hymas N. Deficit in cognitive shifting ability in patients with obsessive-compulsive disorder. Biol. Psychiatry. 25:1989;929-937
121. Herner, T., 1961. Treatment of mental disorders with frontal stereotactic thermo-lesions. A follow-up study of 116 cases. Acta Psychiatr. Scand. (Suppl. 36).
122. Hikosaka K., Watanabe M. Delay activity of orbital and lateral prefrontal neurons of the monkey varying with different rewards. Cereb. Cortex. 10:2000;263-271
123. Hodgkiss A.D., Malizia A.L., Bartlett J.R., Bridges P.K. Outcome after the psychosurgical operation of stereotactic subcaudate tractotomy, 1979-1991. J. Neuropsychiatry Clin. Neurosci. 7:1995;230-234
124. Hoehn-Saric R., Pearlson G.D., Harris G.J., Machlin S.R., Camargo E.E. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am. J. Psychiatry. 148:1991;1243-1245
125. Hoehn-Saric R., Ninan P., Black D.W., Stahl S., Greist J.H., Lydiard B., McElroy S., Zajecka J., Chapman D., Clary C., Harrison W. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch. Gen. Psychiatry. 57:2000;76-82
126. Hoehn-Saric R., Schlaepfer T.E., Greenberg B.D., McLeod D.R., Pearlson G.D., Wong S.H. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Res. 108:2001;89-100
127. Hohagen, F., Winkelmann, G., Rasche-Ruchle, H., Hand, I., Konig, A., Munchau, N., Hiss, H., Geiger-Kabisch, C., Kappler, C., Schramm, P., Rey, E., Aldenhoff, J., Berger, M., 1998. Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br. J. Psychiatry Suppl., 71-78.
128. Hollander E., Aronowitz B.R. Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient. J. Clin. Psychiatry. 60(Suppl. 9):1999;27-31
129. Hollander E., Wong C.M. Obsessive-compulsive spectrum disorders. J. Clin. Psychiatry. 56(Suppl. 4):1995a;3-6. (discussion 53-55)
130. Hollander E., Wong C.M. Body dysmorphic disorder, pathological gambling, and sexual compulsions. J. Clin. Psychiatry. 56(Suppl. 4):1995b;7-12. (discussion 13)
131. Hollander E., Liebowitz M.R., Winchel R., Klumker A., Klein D.F. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am. J. Psychiatry. 146:1989;768-770
132. Hollander E., DeCaria C.M., Nitescu A., Gully R., Suckow R.F., Cooper T.B., Gorman J.M., Klein D.F., Liebowitz M.R. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch. Gen. Psychiatry. 49:1992a;21-28
133. Hollander E., Neville D., Frenkel M., Josephson S., Liebowitz M.R. Body dysmorphic disorder. Diagnostic issues and related disorders. Psychosomatics. 33:1992b;156-165
134. Hollander E., Prohovnik I., Stein D.J. Increased cerebral blood flow during m-CPP exacerbation of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 7:1995;485-490
135. Hollander E., Allen A., Kwon J., Aronowitz B., Schmeidler J., Wong C., Simeon D. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch. Gen. Psychiatry. 56:1999;1033-1039
136. Hollander E., DeCaria C.M., Finkell J.N., Begaz T., Wong C.M., Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol. Psychiatry. 47:2000;813-817
137. Hollerman J.R., Tremblay L., Schultz W. Influence of reward expectation on behavior-related neuronal activity in primate striatum. J. Neurophysiol. 80:1998;947-963
138. Ho Pian K.L., Westenberg H.G., den Boer J.A., de Bruin W.I., van Rijk P.P. Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls. Biol. Psychiatry. 44:1998;367-370
139. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience. 96:2000;651-656
140. Ibanez A., Blanco C., Donahue E., Lesieur H.R., Perez de Castro I., Fernandez-Piqueras J., Saiz-Ruiz J. Psychiatric comorbidity in pathological gamblers seeking treatment. Am. J. Psychiatry. 158:2001;1733-1735
141. Insel, T.R., Winslow, J.T., 1990. Neurobiology of obsessive-compulsive disorder. In: Jenike, M.A., Baer, L., Minichiello, W.E. (Eds), Obsessive-Compulsive Disorders: Theory and Management, second ed. Year Book Medical Publishers, Chicago, pp. 116-131.
142. Insel T.R., Donnelly E.F., Lalakea M.L., Alterman I.S., Murphy D.L. Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. Biol. Psychiatry. 18:1983;741-751
143. Iversen S.D., Mishkin M. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp. Brain Res. 11:1970;376-386
144. Jagger J., Prusoff B.A., Cohen D.J., Kidd K.K., Carbonari C.M., John K. The epidemiology of Tourette's syndrome: a pilot study. Schizophr. Bull. 8:1982;267-278
145. Jaisoorya T.S., Reddy Y.C., Srinath S. The relationship of obsessive-compulsive disorder to putative spectrum disorders: results from an Indian study. Compr. Psychiatry. 44:2003;317-323
146. Jankovic J. Tourette's syndrome. N. Engl. J. Med. 345:2001;1184-1192
147. Jenike, M.A., 1998. Neurosurgical treatment of obsessive-compulsive disorder. Br. J. Psychiatry Suppl., 79-90.
148. Jenike M.A., Baer L., Ballantine T., Martuza R.L., Tynes S., Giriunas I., Buttolph M.L., Cassem N.H. Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients. Arch. Gen. Psychiatry. 48:1991;548-555
149. Jog M.S., Kubota Y., Connolly C.I., Hillegaart V., Graybiel A.M. Building neural representations of habits. Science. 286:1999;1745-1749
150. Jonides J., Smith E.E., Koeppe R.A., Awh E., Minoshima S., Mintun M.A. Spatial working memory in humans as revealed by PET. Nature. 363:1993;623-625
151. Jonnal A.H., Gardner C.O., Prescott C.A., Kendler K.S. Obsessive and compulsive symptoms in a general population sample of female twins. Am. J. Med. Genet. 96:2000;791-796
152. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18:1993;75-113
153. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry. 153:1996;466-476
154. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., Gogos J.A. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4572-4575
155. Karayiorgou M., Sobin C., Blundell M.L., Galke B.L., Malinova L., Goldberg P., Ott J., Gogos J.A. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol. Psychiatry. 45:1999;1178-1189
156. Karno M., Golding J.M., Sorenson S.B., Burnam M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch. Gen. Psychiatry. 45:1988;1094-1099
157. Kawagoe R., Takikawa Y., Hikosaka O. Expectation of reward modulates cognitive signals in the basal ganglia. Nat. Neurosci. 1:1998;411-416
158. Kelly D., Richardson A., Mitchell-Heggs N., Greenup J., Chen C., Hafner R.J. Stereotactic limbic leucotomy: a preliminary report on forty patients. Br. J. Psychiatry. 123:1973;141-148
159. Kelly D., Mitchell-Heggs N. Stereotactic limbic leucotomy - a follow-up study of thirty patients. Postgrad Med. J. 49:1973;865-882
160. Kerbeshian J., Burd L., Pettit R. A possible post-streptococcal movement disorder with chorea and tics. Dev. Med. Child Neurol. 32:1990;642-644
161. Kim J.N., Shadlen M.N. Neural correlates of a decision in the dorsolateral prefrontal cortex of the macaque. Nat. Neurosci. 2:1999;176-185
162. Kiyatkin E.A. Functional significance of mesolimbic dopamine. Neurosci. Biobehav. Rev. 19:1995;573-598
163. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. N.Y. Acad. Sci. 877:1999;445-460
164. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 278:1997;52-58
165. Koran L.M., Thienemann M.L., Davenport R. Quality of life for patients with obsessive-compulsive disorder. Am. J. Psychiatry. 153:1996;783-788
166. Kosslyn S.M., Daly P.F., McPeek R.M., Alpert N.M., Kennedy D.N., Caviness V.S. Jr. Using locations to store shape: an indirect effect of a lesion. Cereb. Cortex. 3:1993;567-582
167. Krawczyk D.C. Contributions of the prefrontal cortex to the neural basis of human decision making. Neurosci. Biobehav. Rev. 26:2002;631-664
168. Kullberg, G., 1977. Differences in effects of capsulotomy and cingulotomy. In: Sweet, W.H., Obrador, S., Martin-Rodriguez, J.G. (Eds.), Neurosurgical Treatment in Psychiatry, Pain and Epilepsy. University Park Press, Baltimore, pp. 301-308.
169. Kwon J.S., Kim J.J., Lee D.W., Lee J.S., Lee D.S., Kim M.S., Lyoo I.K., Cho M.J., Lee M.C. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res. 122:2003;37-47
170. Lacerda A.L., Dalgalarrondo P., Caetano D., Camargo E.E., Etchebehere E.C., Soares J.C. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res. 123:2003a;125-134
171. Lacerda A.L., Dalgalarrondo P., Caetano D., Haas G.L., Camargo E.E., Keshavan M.S. Neuropsychological performance and regional cerebral blood flow in obsessive-compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27:2003b;657-665
172. Leckman J.F., Riddle M.A. Tourette's syndrome: when habit-forming systems form habits of their own? Neuron. 28:2000;349-354
173. Leckman J.F., Grice D.E., Boardman J., Zhang H., Vitale A., Bondi C., Alsobrook J., Peterson B.S., Cohen D.J., Rasmussen S.A., Goodman W.K., McDougle C.J., Pauls D.L. Symptoms of obsessive-compulsive disorder. Am. J. Psychiatry. 154:1997;911-917
174. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol. Psychiatry. 44:1998;1229-1238
175. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23:2000;155-184
176. Le Moal, M., 1995. Mesocorticolimbic dopaminergic neurons. Functional and regulatory roles. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 283-294.
177. Lenane M.C., Swedo S.E., Leonard H., Pauls D.L., Sceery W., Rapoport J.L. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry. 29:1990;407-412
178. Leonard H.L., Lenane M.C., Swedo S.E., Rettew D.C., Gershon E.S., Rapoport J.L. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am. J. Psychiatry. 149:1992;1244-1251
179. Linden R.D., Pope H.G. Jr., Jonas J.M. Pathological gambling and major affective disorder: preliminary findings. J. Clin. Psychiatry. 47:1986;201-203
180. Lindsay M., Crino R., Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br. J. Psychiatry. 171:1997;135-139
181. Ljungberg T., Apicella P., Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. J. Neurophysiol. 67:1992;145-163
182. Lombroso, P.J., Leckman, J.F., 1999. The neurobiology of Tourette's syndrome and tic-related disorders in children. In: Charney, D.S., Nestler, E.J., Bunney, B.S. (Eds.), Neurobiology of Mental Illness. Oxford University Press, New York, pp. 779-787.
183. Lucey J.V., Burness C.E., Costa D.C., Gacinovic S., Pilowsky L.S., Ell P.J., Marks I.M., Kerwin R.W. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive-compulsive disorder (OCD). Br. J. Med. Psychol. 70(Pt 4):1997;403-411
184. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry. 44:1998;151-162
185. Machlin S.R., Harris G.J., Pearlson G.D., Hoehn-Saric R., Jeffery P., Camargo E.E. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am. J. Psychiatry. 148:1991;1240-1242
186. MacLean P.D. Some psychiatric implications of physiological studies on the frontotemporal portion of the limbic system (visceral brain). Electroencephalogr. Clin. Neurophysiol. 4:1952;407-418
187. Malhi G.S., Sachdev P. Novel physical treatments for the management of neuropsychiatric disorders. J. Psychosom. Res. 53:2002;709-719
188. Mallet L., Mesnage V., Houeto J.L., Pelissolo A., Yelnik J., Behar C., Gargiulo M., Welter M.L., Bonnet A.M., Pillon B., Cornu P., Dormont D., Pidoux B., Allilaire J.F., Agid Y. Compulsions, Parkinson's disease, and stimulation. Lancet. 360:2002;1302-1304
189. Marks I.M., Hodgson R., Rachman S. Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment. Br. J. Psychiatry. 127:1975;349-364
190. Marks I.M., Stern R.S., Mawson D., Cobb J., McDonald R. Clomipramine and exposure for obsessive-compulsive rituals. Br. J. Psychiatry. 136:1980;1-25
191. Marks I.M., Lelliott P., Basoglu M., Noshirvani H., Monteiro W., Cohen D., Kasvikis Y. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br. J. Psychiatry. 152:1988;522-534
192. Martin A., Pigott T.A., Lalonde F.M., Dalton I., Dubbert B., Murphy D.L. Lack of evidence for Huntington's disease-like cognitive dysfunction in obsessive-compulsive disorder. Biol. Psychiatry. 33:1993;345-353
193. Martinot J.L., Allilaire J.F., Mazoyer B.M., Hantouche E., Huret J.D., Legaut-Demare F., Deslauriers A.G., Hardy P., Pappata S., Baron J.C., et al. Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta. Psychiatr. Scand. 82:1990;233-242
194. Mataix-Cols D., Rauch S.L., Manzo P.A., Jenike M.A., Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am. J. Psychiatry. 156:1999;1409-1416
195. Mataix-Cols D., Rauch S.L., Baer L., Eisen J.L., Shera D.M., Goodman W.K., Rasmussen S.A., Jenike M.A. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am. J. Psychiatry. 159:2002;263-268
196. Mataix-Cols D., Cullen S., Lange K., Zelaya F., Andrew C., Amaro E., Brammer M.J., Williams S.C., Speckens A., Phillips M.L. Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biol. Psychiatry. 53:2003;482-493
197. Mavissakalian M., Jones B., Olson S., Perel J.M. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. Psychopharmacol. Bull. 26:1990;119-122
198. McDougle C.J., Goodman W.K., Price L.H. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J. Clin. Psychiatry. 55(Suppl.):1994;24-31
199. McDougle C.J., Fleischmann R.L., Epperson C.N., Wasylink S., Leckman J.F., Price L.H. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. J. Clin. Psychiatry. 56:1995;526-528
200. McDougle, C.J., 1999. The neurobiology and treatment of obsessive-compulsive disorder. In: Charney, D.S., Nestler, E.J. Bunney, B.S. (Eds.), Neurobiology of Mental Illness. Oxford University Press, New York, pp. 518-533.
201. McDougle C.J., Epperson C.N., Pelton G.H., Wasylink S., Price L.H. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch. Gen. Psychiatry. 57:2000;794-801
202. McElroy S.L., Hudson J.I., Pope H. Jr., Keck P.E. Jr., Aizley H.G. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders. Am. J. Psychiatry. 149:1992;318-327
203. McElroy S.L., Phillips K.A., Keck P.E. Jr. Obsessive compulsive spectrum disorder. J. Clin. Psychiatry. 55(Suppl.):1994;33-51. (discussion 52-53)
204. McFarland N.R., Haber S.N. Thalamic relay nuclei of the basal ganglia form both reciprocal and nonreciprocal cortical connections, linking multiple frontal cortical areas. J. Neurosci. 22:2002;8117-8132
205. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. Br. J. Psychiatry. 164:1994;459-468
206. McKay D., Todaro J., Neziroglu F., Campisi T., Moritz E.K., Yaryura-Tobias J.A. Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure with response prevention. Behav. Res. Ther. 35:1997;67-70
207. Mega M.S., Cummings J.L., Salloway S., Malloy P. The limbic system: an anatomic, phylogenetic, and clinical perspective. J. Neuropsychiatry Clin. Neurosci. 9:1997;315-330
208. Mellet E., Tzourio N., Crivello F., Joliot M., Denis M., Mazoyer B. Functional anatomy of spatial mental imagery generated from verbal instructions. J. Neurosci. 16:1996;6504-6512
209. Meyer V. Modification of expectations in cases with obsessional rituals. Behav. Res. Ther. 4:1966;273-280
210. Miller L. Cognitive risk-taking after frontal or temporal lobectomy. I. The synthesis of fragmented visual information. Neuropsychologia. 23:1985;359-369
211. Miller E.K. The prefrontal cortex: complex neural properties for complex behavior. Neuron. 22:1999;15-17
212. Millet B., Chabane N., Delorme R., Leboyer M., Leroy S., Poirier M.F., Bourdel M.C., Mouren-Simeoni M.C., Rouillon F., Loo H., Krebs M.O. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am. J. Med. Genet. 116B:2003;55-59
213. Mindus, Jenike, M.A., 1992. Neurosurgical treatment of malignant obsessive compulsive disorder. Psychiatr. Clin. North Am. 15, 921-938.
214. Mindus P., Rasmussen S.A., Lindquist C. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J. Neuropsychiatry Clin. Neurosci. 6:1994;467-477
215. Mink J.W. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatr. Neurol. 25:2001;190-198
216. Mitchell-Heggs N., Kelly D., Richardson A. Stereotactic limbic leucotomy - a follow-up at 16 months. Br. J. Psychiatry. 128:1976;226-240
217. Modell J.G., Mountz J.M., Curtis G.C., Greden J.F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J. Neuropsychiatry Clin. Neurosci. 1:1989;27-36
218. Molina V., Montz R., Martin-Loeches M., Jimenez-Vicioso A., Carreras J.L., Rubia F.J. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. J. Nucl. Med. 36:1995;2234-2238
219. Moore G.J., MacMaster F.P., Stewart C., Rosenberg D.R. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J. Am. Acad. Child. Adolesc. Psychiatry. 37:1998;663-667
220. Morshed S.A., Parveen S., Leckman J.F., Mercadante M.T., Bittencourt Kiss M.H., Miguel E.C., Arman A., Yazgan Y., Fujii T., Paul S., Peterson B.S., Zhang H., King R.A., Scahill L., Lombroso P.J. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol. Psychiatry. 50:2001;566-577
221. Mundo E., Richter M.A., Sam F., Macciardi F., Kennedy J.L. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder? Am. J. Psychiatry. 157:2000;1160-1161
222. Murphy T.K., Goodman W.K., Fudge M.W., Williams R.C. Jr., Ayoub E.M., Dalal M., Lewis M.H., Zabriskie J.B. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am. J. Psychiatry. 154:1997;402-407
223. Nestadt G., Samuels J., Riddle M., Bienvenu O.J., Liang K.Y., LaBuda M., Walkup J., Grados M., Hoehn-Saric R. A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry. 57:2000;358-363
224. Nicolini H., Cruz C., Camarena B., Orozco B., Kennedy J.L., King N., Weissbecker K., de la Fuente J.R., Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol. Psychiatry. 1:1996;461-465
225. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67:2002;53-83
226. Niki H., Watanabe M. Prefrontal and cingulate unit activity during timing behavior in the monkey. Brain Res. 171:1979;213-224
227. Ninan P.T., Rothbaum B.O., Marsteller F.A., Knight B.T., Eccard M.B. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J. Clin. Psychiatry. 61:2000;47-50
228. Nishijo H., Yamamoto Y., Ono T., Uwano T., Yamashita J., Yamashima T. Single neuron responses in the monkey anterior cingulate cortex during visual discrimination. Neurosci. Lett. 227:1997;79-82
229. Nordahl T.E., Benkelfat C., Semple W.E., Gross M., King A.C., Cohen R.M. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology. 2:1989;23-28
230. Noyes R. Jr., Holt C.S., Happel R.L., Kathol R.G., Yagla S.J. A family study of hypochondriasis. J. Nerv. Ment. Dis. 185:1997;223-232
231. Nuttin B., Cosyns P., Demeulemeester H., Gybels J., Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet. 354:1999;1526
232. Otto, M.W., 1990. Neuropsychological approaches to obsessive-compulsive disorder. In: Jenike, M.A., Baer, L., Minichiello, W.E. (Eds.), Obsessive-Compulsive Disorders: Theory and Management. Year Book Medical Publishers, Chicago, pp. 132-148.
233. Otto M.W. Normal and abnormal information processing. A neuropsychological perspective on obsessive compulsive disorder. Psychiatr. Clin. North Am. 15:1992;825-848
234. Papez J.W. A proposed mechanism of emotion. Arch. Neurol. Psychiatry. 38:1937;725-733
235. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Brain Res. Rev. 20:1995a;91-127
236. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res. Rev. 20:1995b;128-154
237. Passingham, R.E., 1993. The Frontal Lobes and Voluntary Action. Oxford University Press, Oxford.
238. Pato M.T., Pato C.N., Pauls D.L. Recent findings in the genetics of OCD. J. Clin. Psychiatry. 63(Suppl. 6):2002;30-33
239. Pauls D.L., Towbin K.E., Leckman J.F., Zahner G.E., Cohen D.J. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. Arch. Gen. Psychiatry. 43:1986;1180-1182
240. Pauls D.L., Alsobrook J.P. 2nd, Goodman W., Rasmussen S., Leckman J.F. A family study of obsessive-compulsive disorder. Am. J. Psychiatry. 152:1995;76-84
241. Paus T. Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat. Rev. Neurosci. 2:2001;417-424
242. Perani D., Colombo C., Bressi S., Bonfanti A., Grassi F., Scarone S., Bellodi L., Smeraldi E., Fazio F. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br. J. Psychiatry. 166:1995;244-250
243. Peterson B.S. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J. Clin. Psychiatry. 57(Suppl. 9):1996;24-34
244. Peterson B.S., Skudlarski P., Anderson A.W., Zhang H., Gatenby J.C., Lacadie C.M., Leckman J.F., Gore J.C. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch. Gen. Psychiatry. 55:1998;326-333
245. Peterson B.S., Leckman J.F., Tucker D., Scahill L., Staib L., Zhang H., King R., Cohen D.J., Gore J.C., Lombroso P. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch. Gen. Psychiatry. 57:2000;364-372
246. Phillips K.A. Body dysmorphic disorder: the distress of imagined ugliness. Am. J. Psychiatry. 148:1991;1138-1149
247. Phillips K.A., Dufresne R.G. Body dysmorphic disorder. A guide for dermatologists and cosmetic surgeons. Am. J. Clin. Dermatol. 1:2000;235-243
248. Phillips, K.A., Dufresne Jr., R.G. 2002. Body dysmorphic disorder: a guide for primary care physicians. Prim. Care 9, 99-111, vii
249. Phillips K.A., Najjar F. An open-label study of citalopram in body dysmorphic disorder. J. Clin. Psychiatry. 64:2003;715-720
250. Phillips K.A., McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. Body dysmorphic disorder: 30 cases of imagined ugliness. Am. J. Psychiatry. 150:1993;302-308
251. Phillips K.A., McElroy S.L., Hudson J.I., Pope H.G. Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J. Clin. Psychiatry. 56(4):1995;41-51. (discussion 52)
252. Phillips K.A., Dwight M.M., McElroy S.L. Efficacy and safety of fluvoxamine in body dysmorphic disorder. J. Clin. Psychiatry. 59:1998;165-171
253. Phillips K.A., Grant J., Siniscalchi J., Albertini R.S. Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics. 42:2001;504-510
254. Phillips K.A., Albertini R.S., Rasmussen S.A. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch. Gen. Psychiatry. 59:2002;381-388
255. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36:1996;359-378
256. Piazza P.V., Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Brain Res. Rev. 25:1997;359-372
257. Piggot, T.A., Seay, S.M., 1998. Biological treatments for obsessive-compulsive disorder. Literature review. In: Swinson, R.P., Antony, M.M., Rachman, S., Richter, M.A. (Eds.), Obsessive-Compulsive Disorder. Theory, Research, and Treatment. Guilford Press, New York, pp. 298-326.
258. Pigott T.A., Seay S.M. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J. Clin. Psychiatry. 60:1999;101-106
259. Potenza M.N., Steinberg M.A., Skudlarski P., Fulbright R.K., Lacadie C.M., Wilber M.K., Rounsaville B.J., Gore J.C., Wexler B.E. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch. Gen. Psychiatry. 60:2003;828-836
260. Prabhakaran V., Narayanan K., Zhao Z., Gabrieli J.D. Integration of diverse information in working memory within the frontal lobe. Nat. Neurosci. 3:2000;85-90
261. Procyk E., Tanaka Y.L., Joseph J.P. Anterior cingulate activity during routine and non-routine sequential behaviors in macaques. Nat. Neurosci. 3:2000;502-508
262. Pujol J., Torres L., Deus J., Cardoner N., Pifarre J., Capdevila A., Vallejo J. Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive-compulsive disorder. Biol. Psychiatry. 45:1999;891-897
263. Purcell R., Maruff P., Kyrios M., Pantelis C. Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function. Biol. Psychiatry. 43:1998;348-357
264. Rapoport J.L. Obsessive compulsive disorder and basal ganglia dysfunction. Psychol. Med. 20:1990;465-469
265. Rapoport J., Elkins R., Langer D.H., Sceery W., Buchsbaum M.S., Gillin J.C., Murphy D.L., Zahn T.P., Lake R., Ludlow C., Mendelson W. Childhood obsessive-compulsive disorder. Am. J. Psychiatry. 138:1981;1545-1554
266. Rasmussen S.A., Tsuang M.T. The epidemiology of obsessive compulsive disorder. J. Clin. Psychiatry. 45:1984;450-457
267. Rasmussen S.A., Tsuang M.T. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am. J. Psychiatry. 143:1986;317-322
268. Rasmussen S.A., Eisen J.L. Epidemiology of obsessive compulsive disorder. J. Clin. Psychiatry. 51(Suppl.):1990;10-13. (discussion 14)
269. Rasmussen S.A., Eisen J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry. 53(Suppl.):1992;4-10
270. Rasmussen S.A., Eisen J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry. 55(Suppl.):1994;5-10. (discussion 11-14)
271. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry. 51:1994;62-70
272. Rauch S.L., Savage C.R., Alpert N.M., Dougherty D., Kendrick A., Curran T., Brown H.D., Manzo P., Fischman A.J., Jenike M.A. Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J. Neuropsychiatry Clin. Neurosci. 9:1997;568-573
273. Rauch S.L., Dougherty D.D., Cosgrove G.R., Cassem E.H., Alpert N.M., Price B.H., Nierenberg A.A., Mayberg H.S., Baer L., Jenike M.A., Fischman A.J. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol. Psychiatry. 50:2001;659-667
274. Rauch S.L., Shin L.M., Dougherty D.D., Alpert N.M., Fischman A.J., Jenike M.A. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 27:2002;782-791
275. Ravel S., Sardo P., Legallet E., Apicella P. Reward unpredictability inside and outside of a task context as a determinant of the responses of tonically active neurons in the monkey striatum. J. Neurosci. 21:2001;5730-5739
276. Ravizza L., Barzega G., Bellino S., Bogetto F., Maina G. Predictors of drug treatment response in obsessive-compulsive disorder. J. Clin. Psychiatry. 56:1995;368-373
277. Ravizza L., Maina G., Bogetto F. Episodic and chronic obsessive-compulsive disorder. Depress Anxiety. 6:1997;154-158
278. Renynghe de Voxrie G.V. Anafranil (G34586) in obsessive-compulsive neurosis. Arch. Neurol. Belg. 68:1968;787-792
279. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6:1996;228-236
280. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain. 123(Pt 3):2000;425-462
281. Robins L.N., Helzer J.E., Weissman M.M., Orvaschel H., Gruenberg E., Burke J.D. Jr., Regier D.A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry. 41:1984;949-958
282. Rolls, E.T., 1999. The neural basis of emotion. In: Rolls, E.T. (Ed.), The Brain and Emotion. Oxford University Press, New York, pp. 112-138.
283. Rolls E.T. The orbitofrontal cortex and reward. Cereb. Cortex. 10:2000;284-294
284. Rosen J.C., Reiter J., Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J. Consult. Clin. Psychol. 63:1995;263-269
285. Rosenberg D.R., MacMaster F.P., Keshavan M.S., Fitzgerald K.D., Stewart C.M., Moore G.J. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J. Am. Acad. Child. Adolesc. Psychiatry. 39:2000;1096-1103
286. Rosenberg D.R., Amponsah A., Sullivan A., MacMillan S., Moore G.J. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J. Child. Neurol. 16:2001;636-641
287. Rubin R.T., Villanueva-Meyer J., Ananth J., Trajmar P.G., Mena I. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Arch. Gen. Psychiatry. 49:1992;695-702
288. Rubin R.T., Ananth J., Villanueva-Meyer J., Trajmar P.G., Mena I. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment. Biol. Psychiatry. 38:1995;429-437
289. Rudin E. Ein beitrag zur frage der zwangskranheit insebesondere ihere hereditaren beziehungen. Archiv. für. Psychiatrie und Nervenkrankheiten. 191:1953;14-54
290. Saint-Cyr J.A., Taylor A.E., Nicholson K. Behavior and the basal ganglia. Adv. Neurol. 65:1995;1-28
291. Salama S.A., Salama A.A. New behavioral approach to trichotillomania. Am. J. Psychiatry. 156:1999;1469-1470
292. Salamone J.D., Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 137:2002;3-25
293. Sardo P., Ravel S., Legallet E., Apicella P. Influence of the predicted time of stimuli eliciting movements on responses of tonically active neurons in the monkey striatum. Eur. J. Neurosci. 12:2000;1801-1816
294. Sasson Y., Zohar J., Chopra M., Lustig M., Iancu I., Hendler T. Epidemiology of obsessive-compulsive disorder: a world view. J. Clin. Psychiatry. 58(Suppl. 12):1997;7-10
295. Savage C.R., Baer L., Keuthen N.J., Brown H.D., Rauch S.L., Jenike M.A. Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol. Psychiatry. 45:1999;905-916
296. Saxena S., Wang D., Bystritsky A., Baxter L.R. Jr. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J. Clin. Psychiatry. 57:1996;303-306
297. Saxena, S., Brody, A.L., Schwartz, J.M., Baxter, L.R., 1998. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry Suppl., 26-37.
298. Saxena S., Brody A.L., Maidment K.M., Dunkin J.J., Colgan M., Alborzian S., Phelps M.E., Baxter L.R. Jr. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 21:1999;683-693
299. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., Huang S.C., Wu H.M., Au S.C., Baxter L.R. Jr. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol. Psychiatry. 50:2001;159-170
300. Saxena S., Brody A.L., Ho M.L., Alborzian S., Maidment K.M., Zohrabi N., Ho M.K., Huang S.C., Wu H.M., Baxter L.R. Jr. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch. Gen. Psychiatry. 59:2002;250-261
301. Scheffers M.K., Coles M.G., Bernstein P., Gehring W.J., Donchin E. Event-related brain potentials and error-related processing: an analysis of incorrect responses to go and no-go stimuli. Psychophysiology. 33:1996;42-53
302. Schindler K.M., Richter M.A., Kennedy J.L., Pato M.T., Pato C.N. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am. J. Med. Genet. 96:2000;721-724
303. Schmahmann J.D., Pandya D.N. The cerebrocerebellar system. Int. Rev. Neurobiol. 41:1997;31-60
304. Schneider J.S. Basal ganglia role in behavior: importance of sensory gating and its relevance to psychiatry. Biol. Psychiatry. 19:1984;1693-1710
305. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80:1998;1-27
306. Schwartz, J.M., 1998. Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. An evolving perspective on brain and behaviour. Br. J. Psychiatry Suppl., 38-44.
307. Schwartz J.M. A role of volition and attention in the generation of new brain circuitry. Toward a neurobiology of mental force. J. Consciousness Stud. 6:1999;115-142
308. Schwartz J.M., Stoessel P.W., Baxter L.R. Jr., Martin K.M., Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry. 53:1996;109-113
309. Shallice M. Specific impairments in planning. Phil. Trans. R. Soc. B. 298:1982;199-209
310. Shima K., Tanji J. Role for cingulate motor area cells in voluntary movement selection based on reward. Science. 282:1998;1335-1338
311. Shimo Y., Hikosaka O. Role of tonically active neurons in primate caudate in reward-oriented saccadic eye movement. J. Neurosci. 21:2001;7804-7814
312. Simeon D., Hollander E., Stein D.J., Cohen L., Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am. J. Psychiatry. 152:1995;1207-1209
313. Simpson S., Baldwin B. Neuropsychiatry and SPECT of an acute obsessive-compulsive syndrome patient. Br. J. Psychiatry. 166:1995;390-392
314. Simpson H.B., Gorfinkle K.S., Liebowitz M.R. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. J. Clin. Psychiatry. 60:1999;584-590
315. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., Kiessling L.S. Antibodies against human putamen in children with Tourette syndrome. Neurology. 50:1998;1618-1624
316. Skoog G., Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]. Arch. Gen. Psychiatry. 56:1999;121-127
317. Slaght S.J., Paz T., Mahon S., Maurice N., Charpier S., Deniau J.M. Functional organization of the circuits connecting the cerebral cortex and the basal ganglia: implications for the role of the basal ganglia in epilepsy. Epileptic Disord. 4(Suppl. 3):2002;9-22
318. Squire, L.R., 1987. Memory and Brain. Oxford University Press, New York.
319. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affect Disord. 51:1998;215-235
320. Stein D.J. Neurobiology of the obsessive-compulsive spectrum disorders. Biol. Psychiatry. 47:2000;296-304
321. Stein D.J., Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J. Clin. Psychiatry. 53:1992;123-126
322. Stein D.J., Simeon D., Cohen L.J., Hollander E. Trichotillomania and obsessive-compulsive disorder. J. Clin. Psychiatry. 56(Suppl. 4):1995;28-34. (discussion 35)
323. Stein M.B., Forde D.R., Anderson G., Walker J.R. Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal. Am. J. Psychiatry. 154:1997a;1120-1126
324. Stein D.J., Bouwer C., Hawkridge S., Emsley R.A. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J. Clin. Psychiatry. 58:1997b;119-122
325. Stein D.J., van Heerden B., Hugo C., van Kradenburg J., Warwick J., Zungu-Dirwayi N., Seedat S. Functional brain imaging and pharmacotherapy in trichotillomania. Single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:2002;885-890
326. Steketee G., Eisen J., Dyck I., Warshaw M., Rasmussen S. Predictors of course in obsessive-compulsive disorder. Psychiatry Res. 89:1999;229-238
327. Stern R.S., Marks I.M., Wright J., Luscombe D.K. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis. Postgrad Med. J. 56(Suppl. 1):1980;134-139
328. Stern E., Silbersweig D.A., Chee K.Y., Holmes A., Robertson M.M., Trimble M., Frith C.D., Frackowiak R.S., Dolan R.J. A functional neuroanatomy of tics in Tourette syndrome. Arch. Gen. Psychiatry. 57:2000;741-748
329. Strom-Olsen R., Carlisle S. Bi-frontal stereotactic tractotomy. A follow-up study of its effects on 210 patients. Br. J. Psychiatry. 118:1971;141-154
330. Summerfeldt L.J., Richter M.A., Antony M.M., Swinson R.P. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav. Res. Ther. 37:1999;297-311
331. Swedo S.E., Leonard H.L. Childhood movement disorders and obsessive compulsive disorder. J. Clin. Psychiatry. 55(Suppl.):1994;32-37
332. Swedo S.E., Rapoport J.L., Leonard H., Lenane M., Cheslow D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch. Gen. Psychiatry. 46:1989a;335-341
333. Swedo S.E., Rapoport J.L., Cheslow D.L., Leonard H.L., Ayoub E.M., Hosier D.M., Wald E.R. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am. J. Psychiatry. 146:1989b;246-249
334. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A., Friedland R., Rapoport S.I., Rapoport J.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry. 46:1989c;518-523
335. Swedo S.E., Rapoport J.L., Leonard H.L., Schapiro M.B., Rapoport S.I., Grady C.L. Regional cerebral glucose metabolism of women with trichotillomania. Arch. Gen. Psychiatry. 48:1991;828-833
336. Swedo S.E., Pietrini P., Leonard H.L., Schapiro M.B., Rettew D.C., Goldberger E.L., Rapoport S.I., Rapoport J.L., Grady C.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch. Gen. Psychiatry. 49:1992;690-694
337. Swedo S.E., Leonard H.L., Mittleman B.B., Allen A.J., Rapoport J.L., Dow S.P., Kanter M.E., Chapman F., Zabriskie J. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am. J. Psychiatry. 154:1997;110-112
338. Takada M., Tokuno H., Nambu A., Inase M. Corticostriatal projections from the somatic motor areas of the frontal cortex in the macaque monkey: segregation versus overlap of input zones from the primary motor cortex, the supplementary motor area, and the premotor cortex. Exp. Brain Res. 120:1998;114-128
339. Tan E., Marks I.M., Marset P. Bimedial leucotomy in obsessive-compulsive neurosis: a controlled serial enquiry. Br. J. Psychiatry. 118:1971;155-164
340. The Clomipramine Collaborative Study Group, 1991. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry 48, 730-738.
341. Thompson J.M., Baxter L.R., Schwartz J.M. Freud, obsessive-compulsive disorder and neurobiology. Psychoanal. Contemp. Thought. 15:1992;483-505
342. Thorpe S.J., Rolls E.T., Maddison S. The orbitofrontal cortex: neuronal activity in the behaving monkey. Exp. Brain Res. 49:1983;93-115
343. Tremblay L., Schultz W. Modifications of reward expectation-related neuronal activity during learning in primate orbitofrontal cortex. J. Neurophysiol. 83:2000;1877-1885
344. Tremblay L., Hollerman J.R., Schultz W. Modifications of reward expectation-related neuronal activity during learning in primate striatum. J. Neurophysiol. 80:1998;964-977
345. Vallone D., Picetti R., Borrelli E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 24:2000;125-132
346. Van Ameringen M., Mancini C., Oakman J.M., Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J. Affect Disord. 56:1999;219-226
347. Veale D., Gournay K., Dryden W., Boocock A., Shah F., Willson R., Walburn J. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav. Res. Ther. 34:1996;717-729
348. Waltz J.A., Knowlton B.J., Holyoak K.J., Boone K.B., Mishkin F.S., de Menezes Santos M., Thomas C.R., Miller B.L. A system for relational reasoning in human prefrontal cortex. Psychol. Sci. 10:1999;119-125
349. Yaryura-Tobias J.A., Neziroglu F. The action of chlorimipramine in obsessive-compulsive neurosis: a pilot study. Curr. Ther. Res. Clin. Exp. 17:1975;111-116
350. Zielinski C.M., Taylor M.A., Juzwin K.R. Neuropsychological deficits in obsessive-compulsive disorder. Neuropsychiatry Neuropsychol. Behav. Neurol. 4:1991;110-126
351. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch. Gen. Psychiatry. 44:1987;946-951
352. Zohar J., Insel T.R., Berman K.F., Foa E.B., Hill J.L., Weinberger D.R. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. Arch. Gen. Psychiatry. 46:1989;505-510